Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence

Author： Russo Antonio   Fratto Maria E   Bazan Viviana   Schiró Valentina   Agnese Valentina   Cicero Giuseppe   Vincenzi Bruno   Tonini Giuseppe   Santini Daniele  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.12, 2007-12, pp. : 1571-1586

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies

By  

Current Medicinal Chemistry, Vol. 15, Iss. 4, 2008-02 ,pp. : 322-338

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targeting of TRPV1 by Resiniferatoxin, from Preclinical Studies to Clinical Trials

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 17, 2011-09 ,pp. : 2159-2170

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence

By Balayssac David   Ferrier Jééréémy   Descoeur Juliette   Ling Bing   Pezet Denis   Eschalier Alain   Authier Nicolas  

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 407-417

Informa Healthcare

Access to resources Recommend Favorite

The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias: A Review of Current Preclinical and Clinical Evidence

By Sani Gabriele   Serra Giulia  

CNS Drugs, Vol. 26, Iss. 8, 2012-08 ,pp. : 663-690

Adis International

Access to resources Recommend Favorite

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 76-86

Bentham Science Publishers

Access to resources Recommend Favorite